|
1
|
Domino EF, Chodoff P and Corssen G:
Pharmacologic effects of CI-581, a new dissociative anesthetic, in
man. Clin Pharmacol Ther. 6:279–291. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shahani R, Streutker C, Dickson B and
Stewart RJ: Ketamine-associated ulcerative cystitis: A new clinical
entity. Urology. 69:810–812. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chu PS, Kwok SC, Lam KM, Chu TY, Chan SW,
Man CW, Ma WK, Chui KL, Yiu MK, Chan YC, et al: 'Street
ketamine'-associated bladder dysfunction: A report of ten cases.
Hong Kong Med J. 13:311–313. 2007.PubMed/NCBI
|
|
4
|
Chu PS, Ma WK, Wong SC, Chu RW, Cheng CH,
Wong S, Tse JM, Lau FL, Yiu MK and Man CW: The destruction of the
lower urinary tract by ketamine abuse: A new syndrome? BJU Int.
102:1616–1622. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jhang JF, Hsu YH and Kuo HC: Possible
pathophysiology of ketamine-related cystitis and associated
treatment strategies. Int J Urol. 22:816–825. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chuang SM, Liu KM, Li YL, Jang MY, Lee HH,
Wu WJ, Chang WC, Levin RM and Juan YS: Dual involvements of
cyclooxygenase and nitric oxide synthase expressions in
ketamine-induced ulcerative cystitis in rat bladder. Neurourol
Urodyn. 32:1137–1143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu D, Huang J, Yin Y, Shan Z, Zheng S and
Wu P: Long-term ketamine abuse induces cystitis in rats by
impairing the bladder epithelial barrier. Mol Biol Rep.
41:7313–7322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu KM, Chuang SM, Long CY, Lee YL, Wang
CC, Lu MC, Lin RJ, Lu JH, Jang MY, Wu WJ, et al: Ketamine-induced
ulcerative cystitis and bladder apoptosis involve oxidative stress
mediated by mitochondria and the endoplasmic reticulum. Am J
Physiol Renal Physiol. 309:F318–F331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Chen Y, Gu D, Zhang G, Chen J,
Zhao J and Wu P: Ketamine-induced bladder fibrosis involves
epithelial-to-mesenchymal transition mediated by transforming
growth factor-β1. Am J Physiol Renal Physiol. 313:F961–F972. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meng E, Chang HY, Chang SY, Sun GH, Yu DS
and Cha TL: Involvement of purinergic neurotransmission in ketamine
induced bladder dysfunction. J Urol. 186:1134–1141. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gu D, Huang J, Shan Z, Yin Y, Zheng S and
Wu P: Effects of long-term ketamine administration on rat bladder
protein levels: A proteomic investigation using two-dimensional
difference gel electrophoresis system. Int J Urol. 20:1024–1031.
2013.PubMed/NCBI
|
|
12
|
Shen CH, Wang ST, Lee YR, Liu SY, Li YZ,
Wu JD, Chen YJ and Liu YW: Biological effect of ketamine in
urothelial cell lines and global gene expression analysis in the
bladders of ketamine-injected mice. Mol Med Rep. 11:887–895. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen CH, Wang SC, Wang ST, Lin SM, Wu JD,
Lin CT and Liu YW: Evaluation of urinary bladder fibrogenesis in a
mouse model of long-term ketamine injection. Mol Med Rep.
14:1880–1890. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watanabe H, Numata K, Ito T, Takagi K and
Matsukawa A: Innate immune response in Th1- and Th2-dominant mouse
strains. Shock. 22:460–466. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kilkenny C, Browne W, Cuthill IC, Emerson
M and Altman DG; National Centre for the Replacement and Refinement
Reduction of Amimals in Research, : Animal research: Reporting in
vivo experiments-the ARRIVE guidelines. J Cereb Blood Flow Metab.
31:991–993. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sugino Y, Kanematsu A, Hayashi Y, Haga H,
Yoshimura N, Yoshimura K and Ogawa O: Voided stain on paper method
for analysis of mouse urination. Neurourol Urodyn. 27:548–552.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cohen SM, Ohnishi T, Clark NM, He J and
Arnold LL: Investigations of rodent urinary bladder carcinogens:
Collection, processing, and evaluation of urine and bladders.
Toxicol Pathol. 35:337–347. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Naba A, Clauser KR, Ding H, Whittaker CA,
Carr SA and Hynes RO: The extracellular matrix: Tools and insights
for the ‘omics’ era. Matrix Biol. 49:10–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Corazza O, Assi S and Schifano F: From
‘Special K’ to ‘Special M’: The evolution of the recreational use
of ketamine and methoxetamine. CNS Neurosci Ther. 19:454–460. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cvrcek P: Side effects of ketamine in the
long-term treatment of neuropathic pain. Pain Med. 9:253–257. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee G: Uroplakins in the lower urinary
tract. Int Neurourol J. 15:4–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Petkov GV: Central role of the BK channel
in urinary bladder smooth muscle physiology and pathophysiology. Am
J Physiol Regul Integr Comp Physiol. 307:R571–R584. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wynn TA: Cellular and molecular mechanisms
of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Petkov GV: Role of potassium ion channels
in detrusor smooth muscle function and dysfunction. Nat Rev Urol.
9:30–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Everds NE, Snyder PW, Bailey KL, Bolon B,
Creasy DM, Foley GL, Rosol TJ and Sellers T: Interpreting stress
responses during routine toxicity studies: A review of the biology,
impact, and assessment. Toxicol Pathol. 41:560–614. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsai TH, Cha TL, Lin CM, Tsao CW, Tang SH,
Chuang FP, Wu ST, Sun GH, Yu DS and Chang SY: Ketamine-associated
bladder dysfunction. Int J Urol. 16:826–829. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Heppner TJ, Bonev AD and Nelson MT:
Ca(2+)-activated K+ channels regulate action potential
repolarization in urinary bladder smooth muscle. Am J Physiol.
273:C110–C117. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hristov KL, Chen M, Kellett WF, Rovner ES
and Petkov GV: Large-conductance voltage- and Ca2+-activated K+
channels regulate human detrusor smooth muscle function. Am J
Physiol Cell Physiol. 301:C903–C912. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hayase M, Hashitani H, Kohri K and Suzuki
H: Role of K+ channels in regulating spontaneous activity in
detrusor smooth muscle in situ in the mouse bladder. J Urol.
181:2355–2365. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kita M, Yunoki T, Takimoto K, Miyazato M,
Kita K, de Groat WC, Kakizaki H and Yoshimura N: Effects of bladder
outlet obstruction on properties of Ca2+-activated K+ channels in
rat bladder. Am J Physiol Regul Integr Comp Physiol.
298:R1310–R1319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Brenner R, Chen QH, Vilaythong A, Toney
GM, Noebels JL and Aldrich RW: BK channel beta4 subunit reduces
dentate gyrus excitability and protects against temporal lobe
seizures. Nat Neurosci. 8:1752–1759. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Khimji AK and Rockey DC:
Endothelin-biology and disease. Cell Signal. 22:1615–1625. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jaggar JH, Porter VA, Lederer WJ and
Nelson MT: Calcium sparks in smooth muscle. Am J Physiol Cell
Physiol. 278:C235–C256. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang T, Kendig DM, Smolock EM and Moreland
RS: Carbachol-induced rabbit bladder smooth muscle contraction:
Roles of protein kinase C and Rho kinase. Am J Physiol Renal
Physiol. 297:F1534–F1542. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang T, Kendig DM, Trappanese DM, Smolock
EM and Moreland RS: Phorbol 12,13-dibutyrate-induced, protein
kinase C-mediated contraction of rabbit bladder smooth muscle.
Front Pharmacol. 2:832012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Picht E, DeSantiago J, Huke S, Kaetzel MA,
Dedman JR and Bers DM: CaMKII inhibition targeted to the
sarcoplasmic reticulum inhibits frequency-dependent acceleration of
relaxation and Ca2+ current facilitation. J Mol Cell Cardiol.
42:196–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kuo IY and Ehrlich BE: Signaling in muscle
contraction. Cold Spring Harb Perspect Biol. 7:a0060232015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lin HC, Lee HS, Chiueh TS, Lin YC, Lin HA,
Lin YC, Cha TL and Meng E: Histopathological assessment of
inflammation and expression of inflammatory markers in patients
with ketamine-induced cystitis. Mol Med Rep. 11:2421–2428. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jhang JF, Hsu YH, Jiang YH, Lee CL and Kuo
HC: Histopathological characteristics of ketamine-associated
uropathy and their clinical association. Neurourol Urodyn.
37:1764–1772. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Duan Q, Wu T, Yi X, Liu L, Yan J and Lu Z:
Changes to the bladder epithelial barrier are associated with
ketamine-induced cystitis. Exp Ther Med. 14:2757–2762. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hills CE, Jin T, Siamantouras E, Liu IK,
Jefferson KP and Squires PE: ‘Special k’ and a loss of cell-to-cell
adhesion in proximal tubule-derived epithelial cells: modulation of
the adherens junction complex by ketamine. PLoS One. 8:e718192013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Martignoni M, Groothuis G and de Kanter R:
Comparison of mouse and rat cytochrome P450-mediated metabolism in
liver and intestine. Drug Metab Dispos. 34:1047–1054.
2006.PubMed/NCBI
|
|
44
|
Rajandram R, Ong TA, Razack AH, MacIver B,
Zeidel M and Yu W: Intact urothelial barrier function in a mouse
model of ketamine-induced voiding dysfunction. Am J Physiol Renal
Physiol. 310:F885–F894. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wight TN: Provisional matrix: A role for
versican and hyaluronan. Matrix Biol. 60-61:38–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Thanigaimani S, Lau DH, Agbaedeng T,
Elliott AD, Mahajan R and Sanders P: Molecular mechanisms of atrial
fibrosis: Implications for the clinic. Expert Rev Cardiovasc Ther.
15:247–256. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nogueira A, Pires MJ and Oliveira PA:
Pathophysiological mechanisms of renal fibrosis: A review of animal
models and therapeutic strategies. In Vivo. 31:1–22. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Juan YS, Lee YL, Long CY, Wong JH, Jang
MY, Lu JH, Wu WJ, Huang YS, Chang WC and Chuang SM: Translocation
of NF-κB and expression of cyclooxygenase-2 are enhanced by
ketamine-induced ulcerative cystitis in rat bladder. Am J Pathol.
185:2269–2285. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim A, Yu HY, Heo J, Song M, Shin JH, Lim
J, Yoon SJ, Kim Y, Lee S, Kim SW, et al: Mesenchymal stem cells
protect against the tissue fibrosis of ketamine-induced cystitis in
rat bladder. Sci Rep. 6:308812016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lee YL, Lin KL, Chuang SM, Lee YC, Lu MC,
Wu BN, Wu WJ, Yuan SF, Ho WT and Juan YS: Elucidating mechanisms of
bladder repair after hyaluronan instillation in ketamine-induced
ulcerative cystitis in animal model. Am J Pathol. 187:1945–1959.
2017. View Article : Google Scholar : PubMed/NCBI
|
